Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test
Having a similar metabolic phenotype to the ob/ob animals, the db/db model exhibits leptin resistance caused by premature termination of leptin receptor transcription (Chen et al., 1996)
Effects of adjunctive N-acetylcysteine on depressive symptoms: modulation by baseline high-sensitivity C-reactive protein
Immune Modulation: The peptide's effects on inflammatory pathways suggest caution for: Active autoimmune conditions Immunocompromised individuals Those taking immunomodulatory medications Populations Requiring Extra Caution Avoid or Use Extreme Caution: Active cancer or history of cancer Pregnancy or breastfeeding Children and adolescents Severe cardiovascular disease Active infections Immediately pre or post-surgery (without medical guidance) Drug Interactions Theoretical Interactions Given BPC-157's mechanisms, theoretical interactions exist with: Medications Affecting NO System: Nitrates (nitroglycerin, isosorbide) PDE5 inhibitors (sildenafil, tadalafil) Some blood pressure medications Reasoning: Combined NO system effects Anticoagulants and Antiplatelets: Warfarin Aspirin Clopidogrel Direct oral anticoagulants Reasoning: Angiogenic effects may affect bleeding Growth Hormone and Related: HGH IGF-1 Other growth-promoting compounds Reasoning: Additive growth factor effects Immunomodulators: Corticosteroids TNF-alpha inhibitors Other immunosuppressants Reasoning: Overlapping immune effects NSAIDs A Special Case Interestingly, while drug interactions are generally concerning, research suggests BPC-157 may protect against NSAID damage
Bibcode:1968Natur.219.1253S
US$ 25.01
US$ 28.48
US$ 23.39
US$ 23.74
US$ 21.03
US$ 21.50
US$ 28.38
US$ 21.20
US$ 24.49
US$ 24.70